Search Results

Test Catalog

ALP - Overview: Alkaline Phosphatase, Serum

Diagnosing and monitoring treatment of liver, bone, intestinal, and parathyroid diseases

BHSF - Overview: Beta-Human Chorionic Gonadotropin, Quantitative, Spinal Fluid

Aiding in the diagnosis of brain metastases of testicular cancer or extragonadal intracerebral germ cell tumors

BARBX - Overview: Barbiturates Confirmation, Chain of Custody, Random, Urine

Detecting drug abuse involving barbiturates such as amobarbital, butalbital, pentobarbital, phenobarbital, and secobarbital Chain of custody is required whenever the results of testing could be used in a court of law. Its purpose is to...

AAT - Overview: Alpha-1-Antitrypsin, Serum

Workup of individuals with suspected disorders such as familial chronic obstructive lung disease Diagnosing alpha-1-antitrypsin deficiency

ASB - Overview: Arsenic, Blood

Detecting acute or very recent arsenic exposure Monitoring the effectiveness of therapy This test is not useful for evaluation of chronic arsenic exposure.

CRWB - Overview: Chromium, Blood

Monitoring exposure to chromium using whole blood specimens Monitoring metallic prosthetic implant wear

CA19 - Overview: Carbohydrate Antigen 19-9 (CA 19-9), Serum

As a potential adjunct for diagnosis and monitoring of pancreatic cancer Potentially differentiating patients with cholangiocarcinoma and primary sclerosing cholangitis (PSC) from those with PSC alone

HDCH - Overview: Cholesterol, High-Density Lipoprotein (HDL), Serum

Measurement of serum high-density lipoprotein concentrations for managing atherosclerotic cardiovascular disease risk

GQ1ES - Overview: Ganglioside GQ1b Antibody, IgG, ELISA, Serum

Evaluating patients with an underlying demyelinating neuropathy Supporting the diagnosis of a ganglioside GQ1b IgG-related disorder

CLOM - Overview: Clomipramine, Serum

Determining whether a poor therapeutic response is attributable to noncompliance Monitoring serum concentration of clomipramine and norclomipramine to assist in optimizing the administered dose

FENR - Overview: Fentanyl Screen with Reflex, Random, Urine

Screening for drug abuse or use involving fentanyl and confirmation of fentanyl if present in the screen

MNRCU - Overview: Manganese/Creatinine Ratio, Random, Urine

Monitoring manganese exposure using random urine specimens Nutritional monitoring Clinical trials

UEBF - Overview: Urea Nitrogen, Body Fluid

Identifying the presence of urine as a cause for accumulation of fluid in a body compartment Assessing adequacy of peritoneal dialysis treatment protocols

TGII - Overview: Thyroglobulin, Interference Interpretation

Interpretation for the evaluation of suspected interference from heterophile antibodies causing a falsely elevated thyroglobulin result

TRYPP - Overview: Tryptophan, Plasma

Investigating inadequate tryptophan intake and monitoring dietary treatment

TICU - Overview: Titanium/Creatinine Ratio, Urine

Measurement of titanium concentration as part of a profile to assess exposure and elimination of titanium

VALPA - Overview: Valproic Acid, Total, Serum

Monitoring total valproic acid in therapy Assessing compliance Evaluating potential toxicity

BUPM - Overview: Buprenorphine and Norbuprenorphine, Random, Urine

Monitoring of compliance utilizing buprenorphine Detection and confirmation of the illicit use of buprenorphine

THCU - Overview: Delta-8 and Delta-9-Carboxy-Tetrahydrocannabinol (THC) Confirmation, Random, Urine

Detection and confirmation of drug use of cannabis/marijuana and to specifically identify and quantify delta-8-carboxy tetrahydrocannabinol (THC-COOH) and delta-9-THC-COOH

AACYL - Overview: Aminoacylase-1 Deficiency, Urine

Follow-up quantitation of abnormal organic acid elevations of N-acetylated amino acids, in particular N-acetylalanine, N-acetylglycine, N-acetylmethionine, and N-acetylglutamic acid Diagnosis of individuals with aminoacylase-1...

Site Search

mdazl-rhode-island-certification.pdf

0 Q £ IS l -t1 .,. ... ';.� +"'" ¾liNT 0� State of Rhode Island DEPARTMENT OF HEALTH Center for Health Facilities Regulation This is to certify that MAYO CLINIC MOLECULAR...

newborn_screen_follow-up_for_x-linked_adrenoleukodystrophy.pdf

(MFMER). All rights reserved. 03/2023 Newborn screen result: Elevated lysophosphatidylcholines C24:0, C26:0 Order POX / Fatty Acid Profile, Peroxisomal (C22-C26), Serum Elevated very long chain fatty a....

galactosemia_testing_algorithm.pdf

07/2024 GALT <24.5 nmol/h/mg of hemoglobin GALT ≥24.5 nmol/h/mg of hemoglobin 2 variants identified 0–1 variants identified and discordant enzyme results 1 variant identif......

critical-values-semi-urgent-results-list.pdf

High Units Activated Partial Thromboplastin Time, Plasma Any – ≥ 150 sec Fibrinogen Any ≤ 60 – mg/dL 0 – 7 weeks ≤ 6.0 ≥ 24.0 g/dL > 7 weeks ≤ 6.0 ≥ 20.0 g/dL INR (International Normalizing Ratio......

vitamin_b12_deficiency_evaluation.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 03/2022 Vitamin B12 Deficiency Evaluation <150 ng/L>400 ng/L 150-400 ng/L ≤0.4 nmol/mL >0.4 nmol/mL INDETERMINATE ACASM / Pernicious Anemia Cascade,...